Roche Phase III study misses COVID-19 endp...Swiss Roche AG has missed the primary endpoint in the REMDACTA trial in patients with severe COVID-19 pneumonia. more ➔
BioPhero A/S raises US$17m in Series A fun...Danish sustainable crop protection company, BioPhero AS, has raised $17m in Series A funding led by DCVC Bio. more ➔
PCR-test reveals risk of genotoxity of gen...German researchers have presented a new method to assess on-target and off-target effects of CRISPR-Cas nucleases or TALENs. more ➔
EMA starts rolling review for Sputnik V va...EMAs human medicines committee has started a rolling review of Sputnik V, a COVID-19 vaccine developed by Russias Gamaleya National Centre of Epidemiology and Microbiology. more ➔
CAC builds biofuel plant for OMVChemieanlagenbau Chemnitz (CAC) is realizing one of the first large-scale plants in Europe to use innovative co-processing to produce carbon-neutral fuels. more ➔
French biotech investors launch spin-out a...Kurma Parnters and Francee investment bank have launched a €50m project named Argobio that is aimed at identifiying the most genious biotech ideas and spin out companies. more ➔
Oxular Ltd raises US$37mBritish Oxular Ltd has raised $37m in a financing round led by Forbion Parners and co-financed by IP Group, NeoMed, and V-Bio Ventures to push its pipeline. more ➔
EU life science PPPs face less budget in H...The European Commission is set to fund ten "European Partnerships" partnered with different industries with €10bn. more ➔
MosaMeat BV closes US$85m Series B financi...Cultured meat producer MosaMeat BV has announced the third and final closing of its Series B round raising US$85m. more ➔
Biomarker identifies high-risk COVID-19 pa...Austrian researchers have found that a lack of activation of the NK receptor is highly associated with severe COVID-19 disease courses. more ➔
